Oral Solid Dosage Manufacturing market Growth Analysis by 2035

Comments · 570 Views

Service providers have introduced the latest upgrades in their portfolio in order to achieve a competitive edge. These upgrades primarily target upstream bottlenecks related to the development and manufacturing of oral solids, such as low solubility, poor bioavailability, bitter taste, and

Further, they also aim to streamline the manufacturing of complex formulations, including fixed dose combinations, orally disintegrating tablets, minitablets, flavored chewables, and double-layered tablets.

The financial opportunity within the oral solid dosage contract manufacturing market has been analyzed across the following segments:

Type of Finished Dosage Form

Tablets

Capsules

Granules

Powders

Others

Type of Packaging

Bottles

Blisters

Sachets

Strips

Stick Packs

Scale of Operation

Pre-commercial

Commercial

Company Size

Small

Mid-sized

Large

Very Large

Therapeutic Areas

Oncological Disorders

Cardiovascular Disorders

Metabolic Disorders

Neurological Disorders

Genetic Disorders

Respiratory Disorders

Immunological Disorders

Other Disorders

Key Geographical Regions

North America

Europe

Asia-Pacific

Latin America

Middle East and North Africa

The Oral Solid Dosage Manufacturing Market, 2023-2035 report also includes profiles of key players (listed below) engaged in manufacturing bioreactors and fermenters; each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.

Aenova

Alcami

Almac

Cambrex

Catalent

Hetero Drugs

Ind-Swift

Lonza

Rubicon Research

Table of Contents

1. Preface

2. Executive Summary


3. Introduction

4.OSD Manufacturing Organizations (CMOs): Market Landscape

5. Company Competitiveness Analysis

6. Regional Capability Analysis

7. Company Profiles

8. Make vs Buy Decision Framework

9.Recent Expansions

10. Capacity Analysis

11. Demand Analysis

12. Total Cost of Ownership for Oral Solid Dosage Contract Manufacturing Organizations

13. Regulatory Landscape for Oral Solid Dosage Contract Manufacturers

14. Case Study on Taste Masking Services and Technologies: Market Landscape

15. Case Study on Bioavailability Enhancement Technologies: Market Landscape

16. Market Forecast

17. Executive Insights

18. Concluding Remarks

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html

News article

Bispecific Antibodies Market

Learn from experts: do you know about these emerging industry trends?

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Novel Cell Cytometers: Need of the Hour

About Roots Analysis

Roots Analysisis a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

Comments